SCHEMBL14513579

SCHEMBL14513579

CCc1c2c(OC)c(OC)ccc2cc2[n+]1CCc1cc3c(cc1-2)OCO3

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 9/20 0.60
ACHE P22303 8/20 0.60
EP300 Q09472 4/20 0.60
ALDH1A1 P00352 2/20 0.60
LMNA P02545 2/20 0.60
CYP3A4 P08684 2/20 0.60
CYP2D6 P10635 2/20 0.60
MAPT P10636 2/20 0.60
CHRM1 P11229 2/20 0.60
DRD2 P14416 2/20 0.60
TSHR P16473 2/20 0.60
ADRA2B P18089 2/20 0.60
ADRA2C P18825 2/20 0.60
RXRA P19793 2/20 0.60
DRD1 P21728 2/20 0.60
HTR2B P41595 2/20 0.60
HTT P42858 2/20 0.60
RAD52 P43351 2/20 0.60
KCNH2 Q12809 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14513586 0.92 BCHE (0.58) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL14513583 0.91 BCHE (0.57) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL2742519 0.88 BCHE (0.55) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL14513580 0.87 BCHE (0.63) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL14513581 0.87 BCHE (0.63) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL298574 0.86 BCHE (0.62) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL26312242 0.83 BCHE (0.59) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL14513588 0.82 BCHE (0.58) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL14513578 0.82 P2RX7 (0.46) BCHEACHEEP300ALDH1A1LMNA
SCHEMBL15624081 0.76 BCHE (0.52) BCHEACHEEP300ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070098649-A1 Method and composition for controlling oral pathogens THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (IL) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070098649-A1 Method and composition for controlling oral pathogens BROX, NOP2, FBL BCHE 85/4885ACHE 1348/4885EP300 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.